Xaira Therapeutics Releases Largest Perturb-Seq Dataset to Power the Virtual Cell
Xaira Therapeutics, a spinout of the University of Washington’s Institute for Protein Design (IPD), recently released the largest publicly available Perturb-seq dataset to research how cells respond to external conditions at scale.
Named X-Atlas/Orion, the dataset contains information from eight million cells, each deeply sequenced to capture over 16,000 unique molecular identifiers (UMIs) per cell. “When we put datasets like this in the hands of other computational researchers, we’re excited to see what kind of new model architecture and approaches they can come up with,” said Ci Chu, PhD, vice president of early discovery at Xaira.
This milestone reflects Washington state’s leadership in combining life science and artificial intelligence to advance transformative biomedical research.